FDA Schedules Town Hall On Risk Based Inspections Under New QMSR Framework
March 19, 2026
You are not permitted to access this page. Please purchase membership to get full access to all articles.
Become a Member
Source: FDA
The U.S. Food and Drug Administration (FDA) has announced a Town Hall on April 1, 2026, to explain how inspections of medical device manufacturers will change under its new Quality Management System Regulation (QMSR), with a focus on a risk-based approach.
Most popular news
-
Updated ISO 21001 for Educational Management Moves Focus to Learners and SustainabilityOctober 15, 2025ISO 9001 Revision: Draft International Standard Published, Public Inquiry StartsSeptember 2, 2025Final Weeks Before Transition Deadline for ISO 27001: Act by End of OctoberOctober 8, 2025ISO 17020 Reaches Final Global Vote toward 2026 ReleaseDecember 10, 2025NIST Launches AI Agent Standards Initiative To Address Security And InteroperabilityFebruary 26, 2026France Makes Nutri-Score Labeling Mandatory, But Excludes Traditional Food ProductsNovember 13, 2025Latest Part of ISO 19650 Series Covers Health and Safety Information in BIMSeptember 2, 2025AIAG–VDA Release Harmonized SPC Yellow Volume for Automotive IndustryFebruary 4, 2026ISO 14001:2026 Final Draft Sets New Rules for Climate, Biodiversity and DocumentationDecember 10, 2025EU: Public Consultation Opens on EN 18286, First Standard Supporting the AI ActNovember 13, 2025